Funding
Turn ideas into impact
Show Me
Due: October 7, 2026
DoW Pancreatic Cancer Research Program, Translational Research Partnership Award
Type
Grant
Source
Federal
Opp Number
HT942526PCARPTRPA
Due: October 7, 2026
DoW Pancreatic Cancer Research Program, Idea Development Award
Type
Grant
Source
Federal
Opp Number
HT942526PCARPIDA
Due: October 7, 2026
DoW Pancreatic Cancer Research Program, Focused Pilot Award
Type
Grant
Source
Federal
Opp Number
HT942526PCARPFPTA
Due: October 11, 2026
Addressing Methodological Challenges with Clinical Trials of Rapid-Acting Psychotropic Interventional Drugs (RAPIDs) (R01 Clinical Trial Required)
Type
Grant
Source
Federal
Opp Number
RFA-MH-27-135
Due: October 14, 2026
DoW Melanoma Research Program Team Science Award
Type
Grant
Source
Federal
Opp Number
HT942526MRPTSA
Due: October 14, 2026
NCI Pathway to Independence Award for Early-Stage Postdoctoral Researchers (K99/R00 – Independent Clinical Trial Not Allowed)
Type
Grant
Source
Federal
Opp Number
PAR-23-286
Due: October 14, 2026
NCI Pathway to Independence Award for Early-Stage Postdoctoral Researchers (K99/R00 – Independent Clinical Trial Required)
Type
Grant
Source
Federal
Opp Number
PAR-23-287
Due: October 14, 2026
NCI Pathway to Independence Award for Early-Stage Postdoctoral Researchers (K99/R00 – Independent Basic Experimental Studies with Humans Required)
Type
Grant
Source
Federal
Opp Number
PAR-23-288
Due: October 14, 2026
DoW Melanoma Research Program Focused Program Award – Rare Melanomas
Type
Grant
Source
Federal
Opp Number
HT942526MRPFPARM
Submit your funding opportunity.
Do you have a grant, incentive, funding competition, or other funding source to share?